Sagespring Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.16M Sell
4,395
-507
-10% -$275K 0.04% 186
2025
Q4
$2.84M Buy
4,902
+1,193
+32% +$675K 0.05% 158
2025
Q3
$1.8M Buy
3,709
+1,246
+51% +$580K 0.04% 199
2025
Q2
$999K Sell
2,463
-650
-21% -$272K 0.02% 282
2025
Q1
$1.55M Buy
3,113
+725
+30% +$393K 0.04% 185
2024
Q4
$1.24M Buy
+2,388
New +$1.31M 0.03% 191

Other funds holding TMO

Sagespring Wealth Partners's TMO Position: Q1 2026 in Review

Sagespring Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 10% in Q1 2026, selling an estimated $275K and leaving 4,395 shares worth $2.16M. The position accounts for 0.04% of the portfolio, ranked #186.

Sagespring Wealth Partners first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.84M in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Sagespring Wealth Partners held 4,395 shares of Thermo Fisher Scientific worth $2.16M as of Q1 2026.
  • Sagespring Wealth Partners sold 507 Thermo Fisher Scientific shares in Q1 2026, an estimated $275K.
  • Thermo Fisher Scientific made up 0.04% of Sagespring Wealth Partners's portfolio in Q1 2026, its #186 holding.
  • Sagespring Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Sagespring Wealth Partners's Thermo Fisher Scientific position peaked at $2.84M in Q4 2025.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.